secwatch.observer — SEC 8-K summary
======================================

Issuer:     PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
CIK:        0001552189
Form:       8-K
Filed at:   2023-02-14T23:59:59+00:00
Accession:  0001493152-23-004634
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Panacea Life Sciences agrees to repay $385K convertible note via cash and equity conversion
--------------------------------------------------------------------------------

- Company to pay $135,000 funded under CEO line of credit on Feb 13, 2023; $100,000 by June 30, 2023.
- Conversion of 540,000 common shares at fixed price of $0.25 per share to satisfy remaining balance.
- Note Payoff Agreement dated Feb 9, 2023 amends prior Share Exchange Agreement from March 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552189/000149315223004634/0001493152-23-004634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552189/000149315223004634/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer